CROI 2024 Abstract eBook

Abstract eBook

Search Term Index

M184V/I 693 mAb combination 376 Macaque 366, 1132

Motivational Interviewing 1201 Moxifloxacin 872 MPER 372 Mpox 198, 417, 418, 419, 420, 421, 422, 423, 424, 425, 426, 427, 428, 430, 1079, 1088 Mpox testing 1079 Mpox vaccine 417, 427, 430 Mpox virus 416 MPXV 198 MRI 560, 564 mRNA 523, 525 mRNA vaccine 107, 180, 399 MSM 127, 193, 427, 612, 703, 720, 721, 755, 1080, 1121, 1158, 1170, 1225 mTOR 340 Mucosa 316, 431 Mucosal 383 Mucosal barrier 317 Mucosal immunology 431, 433, 434, 1175 Multi-month dispensing 1234 Multidrug resistance 631, 690, 691, 988 Multiomic approach 444

NHP 412 Nirmatrelvir 135, 429, 660, 661, 662, 668 Nitric oxide 567, 774, 777 NK cells 319, 439, 440, 445, 506, 543 NKT cell 323 NNRTI 636 NNRTI resistance 629, 636 NOD-like receptor 402 NODDI 588 Non-AIDS 752, 822 Non-AIDS-defining cancers (NADC) 752, 753 Non-calcified plaque 773 Non-neutralizing antibody 527, 537 Nonalcoholic fatty liver disease 744 Nonalcoholic steatosis 744 Noncalcified plaque 151 Noncommunicable disease 791, 842, 1056, 1252 Nonhuman primate 180, 341, 529, 816 Nonpathogenic infection 365 Nonresponse 209 Nuclear import 303 Nurse-based 1143 Obesity 626, 797, 808, 816, 825, 917 Observational 982 Observational cohort 416, 860 OC43 403 Occupational 1026 Older people with HIV 643, 838 Omicron 146, 664, 665, 672, 849, 863 Omics 343, 817 On-demand 612 Opioid 995 Opioid use 995, 997 Opioid use disorder 1007 Opportunistic infection 888, 889 Opt out 205 Optimized background regimen 630 Oral antiviral 660 Oral PrEP 1124, 1195 Orthopoxvirus 428 Nonsuppressed 473 North Carolina 1075 Notch signaling 535 Novel antiretroviral drugs 519 NRTTI 115, 129, 638 Nsp1 141

596, 613, 754, 815, 830, 833, 1210 PEP 1131, 1134, 1151

PEPFAR 791 Peptide 404 Perfusion 560 Perinatal 934, 968

Macaque model 104, 177, 341 Machine learning 376, 545, 989 Macrophage 327, 501, 831 MAFLD 800 Magnetic resonance imaging 584, 588 Malawi 202 Male 1122 Male circumcision 190 Malignancy 753 Maraviroc 481 Marginalized 1092 Marijuana 1004 Maternal 923, 930, 936 Mathematical model 1166, 1177, 1229 ME/CFS 563, 855 Mediation 843 Medicaid 1006, 1185 Medicaid expansion 1129 Medicare 995, 1232 Medication 1007 Megakaryocyte 347 Memory 109, 569 Memory-like NK cells 443 Memory CD4 T cell 489 Men who have sex with men 124, 125, 330, 426, 722, 761, 998, 999, 1031, 1032, 1080, 1115, 1119, 1123, 1140, 1153, 1190, 1193 Meningitis 572, 887 Meningoencephalitis 572 Menopause 155, 359, 821 Mental health 189, 547, 573, 851, 976, 979, 996, 1048, 1179, 1187 Mental health care 1049, 1227 Mentor mothers 907 Merkel cell carcinoma 765 MERS-CoV 141 Metabolic 584, 811 Metabolic dysfunction-associated steatotic liver disease 771 Metabolic outcomes 814 Metabolic reprogramming 505, 578 Metabolic syndrome 811, 816 Metabolomics 336, 337, 924 Metagenomic 1154 Methamphetamine 356, 614, 998, 999, 1032 Mexico 679 mHealth 169, 1220 MI 633 Microbial dysbiosis 331 Microbial translocation 336, 338, 836 Microbiome 330, 332, 333, 336, 364, 499, 563, 744, 767, 1154, 1174 Microbiota 330, 332, 744, 819

Perinatal HIV 177, 455, 513, 548, 899, 903, 919, 951, 953, 954, 956, 957, 971, 972, 978, 979, 988 Perinatal transmission 952 Persistence 138, 424, 462, 473, 493, 499, 851, 936, 952, 1191 Persons who use drugs 996, 1189 Peru 1218, 1220 PET imaging 105, 109, 111, 502, 795 Pharmacokinetics 130, 170, 188, 607, 608, 615, 653, 710, 711, 869, 870, 900, 941, 942, 943, 946 Pharmacology 428, 607, 618, 871 Pharmacometrics 607, 950 Pharmacovigilance 805 Pharmacy 1173 Phase I 100, 115, 129, 619, 674 Phase Ib 120 Phase II/III 630 Phenotype 583, 596 Phenotypic age acceleration 839 Phenotypic susceptibility 681 PHIA 196 Pharmacodynamics 558 Pharmacoequity 1245 Pharmacogenetic 556, 606, 870 Phone contact tracing 1093 Phosphatidylethanol 1002 PHQ-9 110 Phylodynamic 1015, 1070, 1085 Phylogenetic 1066, 1069 Phylogenetics 194, 1063, 1065, 1067 Phylogeography 1067, 1070 Physical activity 810 Physical function 152, 799, 838 Pitavastatin 152 PK/PD 612, 618 Place of birth 1016 Placenta 928 Plasma 403 Plasma proteomics 324, 361, 794 Platelet 347 PLWH 914 PMTCT 907 Point-of-care testing 712, 959, 1087, 1114 Point of care 652, 1089, 1111, 1112 Policy 676 Pollution 581 Polymerase chain reaction 1084 Polymorphism 304 Polypharmacy 555, 843 Polyreactivity 384 Polyunsaturated fatty acid 809 PopPK 944, 950 Population-based 195, 196, 197, 861, 1028, 1192 Population level 165, 1188, 1225 Population PK modeling 945, 1097 Post-acute COVID-19 syndrome 138, 563, 568, 846, 847, 849, 852, 854 Post-acute sequelae of SARS-CoV-2 infection 346, 848 Post-COVID Conditions 657 Postexposure prophylaxis 125, 611, 1130, 1131, 1132, 1133, 1134, 1135, 1149, 1150, 1173 Postpartum 182, 183, 711, 901, 902, 904, 908, 914, 916 Posttreatment controller 447, 486, 506 Potency 634 PPV 128 Pre-exposure prophylaxis 115, 129, 427, 677, 1010 Preclinical 421, 509, 615, 633, 880

Multiplex 1101 Muscle 152, 799 Mutation 683 Myco/F Lytic 896 Mycobacteria 896

Mycobacterium tuberculosis 157, 373, 882 Myeloid-derived suppressor cells 326, 731 Myeloid cell 350, 452 Myocardial 795 Myocardial fibrosis 780, 794 Myocarditis 398 N antigen 562 N6 374 N6LS 639

NADC 154, 757 Nadir CD4 759 NAFL 747 NAFLD 747, 972 Naive 774 Nanomedicine 655

Nanoparticle 443, 525 Natural disasters 1205 Natural immunity 315, 416 Natural killer cell 104, 315, 339, 443, 455, 511, 527, 540, 951, 969 Navigation 697 Need 1187 Neonatal ART 184 Neonate 930, 941, 942, 943 Neotropical primates 308 Network 1011, 1063 Network analysis 1011, 1012, 1211 NeuroAIDS 558 Neurocognition 544, 548, 975 Neurocognitive 547, 552, 597 Neurocognitive disorder 563, 603 Neurocognitive impairment 112, 546, 549, 551, 558, 578, 585, 601 Neurodegeneration 586 Neurodevelopment 557, 937, 938, 939 Neurofilament light 546, 577, 598 NeuroHIV 112, 114, 558, 574, 588 Neuroimaging 547, 583, 586, 588, 589, 590, 601 Neuroinflammation 551, 562, 574, 575, 577, 579 Neurological 562 Neuronal injury 574 Neuropathogenesis 588 Neuropsychiatric 554, 556, 594, 596 Neuropsychology 975 Neutralizing antibody 412 Neutralization breadth 373, 438 Neutralization fingerprinting 102 Neutralizing antibodies 506 Neutralizing antibody 379, 382, 482, 503 Neutrophil 346 Next-generation sequencing 1071 Next generation sequencing 139, 897 NGS 693 NHAS 1052 Neutralization 100, 853 Neutralization assay 403

Osteoblast 779 Osteoclast 779 Out-of-pocket 1117 Outbreak 425, 426, 1015 Outcomes 759 Outpatient 667 Outreach 1088 Overdose 1007, 1055 Oxidative 505 Oxidative phosphorylation 436 Oxylipin 809 P-TEFb 479 P24 349 Pancreatic beta cell stress 971 Pap smear 1163 PASC 562, 855 Pathogenesis 366, 854 Pathogenic network 339

Microglia 575 MicroRNA 829

Microvesicle 567, 774 Migrants 706, 1069 Migration 1070 MIS-C 398 Mitochondria 400 Mitochondrial DNA 582 Mitochondrial respiration 400 Mixed effects models 1041

Search Term Index

Patient-reported outcome 631, 843 Patient-reported outcomes 1179 Patient perspectives 622 Pattern recognition receptor 454 PBMCs 610, 685 PBPK 616 PBPK modeling 947 PCOLCE 151 PD-1 blockade 106, 529 Pediatric 185, 408, 513, 940, 944, 945, 982, 986, 989 Pediatric HIV 455, 937, 947, 951, 952, 953, 958, 990 Peer-supported 907, 991, 1222 People living with HIV 357, 385, 722, 840, 903, 996, 1006, 1036, 1079, 1179, 1208, 1209 People who inject drugs 160, 697, 722, 998, 1006, 1008, 1009, 1010, 1012, 1015, 1086, 1140 People with HIV 109, 348, 416, 423, 440, 570,

MK-8527 638 Mobile 1025

Mobile health 991, 992 Mobility 201, 799, 1025 Model 1058 Modeling 1190 Molecular diagnostics 712 Molecular epidemiology 425, 1015, 1063, 1064, 1070 Molnupiravir 136, 660, 662, 667, 668 Monoclonal antibodies 661, 662 Monoclonal antibody 619, 669 Monocyte 442, 455, 456, 469, 501 Monocyte-derived macrophages 307 Monocyte activation 339, 883 Mortality 143, 355, 595, 699, 859, 962, 1003, 1033, 1048, 1053, 1054, 1056, 1057, 1058, 1059, 1060, 1072, 1184 Mortality rate 1003, 1055

Preconception 929 Prediction 102, 615 Predictive modeling 328, 512 Predictive modelling 1066 Predictors 759

CROI 2024 442